It is a pharma private limited company based in Bangalore, Karnataka, India, established in 2017.
2017 | Bangalore, Karnataka, India | ActiveMandev Surgipharma Private Limited, a active private limited company, was established on 11 September 2017 in Bangalore, Karnataka, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74999KA2017PTC106287. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹0.49 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Ranjeet Kumar Jain (Director), Sanjay Kumar Jain (Director), Rakesh Kumar Jain (Director). Past directors included Fathe Chand. It holds ₹1.95 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Fateh Tower, No.1, G T Road, 1St Cross, Cottonpet Road,, Bangalore, Karnataka, 560053.
U74999KA2017PTC106287
106287
11 September 2017
₹0.49 M
₹0.10 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Mandev Surgipharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ranjeet Kumar Jain | Director | 11 Sep 2017 | Current |
| Sanjay Kumar Jain | Director | 11 Sep 2017 | Current |
| Rakesh Kumar Jain | Director | 11 Sep 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 29 Aug 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Mandev Surgipharma Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 3% increase. The company also saw a substantial improvement in profitability, with a 32.32% increase in profit. The company's net worth Soared by an impressive increase of 40.94%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Mandev Surgipharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹19,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Nov 2018 | Others | ₹1.95 Cr | Open |
Explore comprehensive loan charge details -
Mandev Surgipharma has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Mandev Surgipharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mandev Surgipharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Mandev Surgipharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
Mandev Surgipharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was recorded as a recent event.
A charge with Others amounted to Rs. 19.50 M with Charge ID 100221148 was registered on 16 Nov 2018. was recorded as a recent event.
Ranjeet Kumar Jain was appointed as a Director was appointed as a Director on 11 Sep 2017 & has been associated with this company since 8 years 3 months . was recorded as a recent event.
Sanjay Kumar Jain was appointed as a Director was appointed as a Director on 11 Sep 2017 & has been associated with this company since 8 years 3 months . was recorded as a recent event.
The activity Rakesh Kumar Jain was appointed as a Director was appointed as a Director on 11 Sep 2017 & has been associated with this company since 8 years 3 months . was completed.
The CIN of Mandev Surgipharma Private Limited is U74999KA2017PTC106287.
Mandev Surgipharma Private Limited is headquartered at Fateh Tower, No.1, G T Road, 1St Cross, Cottonpet Road,, Bangalore, Karnataka, 560053.
Mandev Surgipharma Private Limited was incorporated on 11 September 2017.
The current directors of Mandev Surgipharma Private Limited are
The primary industry of Mandev Surgipharma Private Limited is Trade.
Mandev Surgipharma Private Limited is unlisted.
The authorized capital of Mandev Surgipharma Private Limited is ₹0.49 M, and the paid-up capital is ₹0.10 M.
The compliance status of Mandev Surgipharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX